These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8185343)
1. [Early phase II study of FUT-187 (sepimostat mesilate) on reflux esophagitis--mainly on postgastrectomy reflux esophagitis]. Abe O; Yoshino K; Kimura K; Suzuki H; Aoki T; Hiki Y; Mitomi T; Makuuchi H Gan To Kagaku Ryoho; 1994 May; 21(6):845-52. PubMed ID: 8185343 [TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of FUT-187 (sepimostat mesilate) on reflux esophagitis and gastritis after gastrectomy]. Makuuchi H; Kanno K; Mitomi T Gan To Kagaku Ryoho; 1995 May; 22(6):777-83. PubMed ID: 7755385 [TBL] [Abstract][Full Text] [Related]
3. [Clinical effects of FUT-187 in reflux esophagitis after gastrectomy]. Toge T; Hirai T; Takiyama W; Takashima N; Kawano K; Tamura Y; Nishimawari K; Iwamori S; Nakanishi K; Kono H Gan To Kagaku Ryoho; 1995 Mar; 22(4):539-46. PubMed ID: 7887646 [TBL] [Abstract][Full Text] [Related]
4. [Effect of FUT-187, oral serine protease inhibitor, on inflammation in the gastric remnant]. Shiozaki H; Inoue M; Tamura S; Iwanaga T; Imaoka M; Furukawa H; Hiratsuka M; Kikkawa N; Kobayashi K; Okamura J; Takada N; Ogawa Y; Yamada T; Takami M; Takada T; Okuda H; Yano T; Satomi T; Kawasaki T; Oshima S; Yamasaki K; Imamoto H; Noguchi S; Fujimoto N; Mori T Gan To Kagaku Ryoho; 1996 Dec; 23(14):1971-9. PubMed ID: 8978806 [TBL] [Abstract][Full Text] [Related]
5. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity. Kono K; Takahashi A; Sugai H; Umekawa T; Yano T; Kamiyasu K; Teramatsu M; Fujii H Am J Surg; 2005 Sep; 190(3):412-7. PubMed ID: 16105528 [TBL] [Abstract][Full Text] [Related]
6. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis. Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S; Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850 [TBL] [Abstract][Full Text] [Related]
7. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group. Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189 [TBL] [Abstract][Full Text] [Related]
8. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis]. Rohner HG; Wienbeck M Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593 [TBL] [Abstract][Full Text] [Related]
9. Esophageal reflux after total or proximal gastrectomy in patients with adenocarcinoma of the gastric cardia. Hsu CP; Chen CY; Hsieh YH; Hsia JY; Shai SE; Kao CH Am J Gastroenterol; 1997 Aug; 92(8):1347-50. PubMed ID: 9260804 [TBL] [Abstract][Full Text] [Related]
10. Total gastrectomy reconstructed by interposition of a jejunal J pouch with preservation of hepatic vagus branch and lower esophageal sphincter for T2 gastric cancer without lymph node metastasis. Tomita R; Tanjoh K; Fujisaki S Hepatogastroenterology; 2004; 51(58):1233-40. PubMed ID: 15239286 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage]. Vasil'ev IuV; Li IA Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of mild to moderate reflux esophagitis with the H2-blocker famotidine]. Kratochvil P; Brandstätter G; Janisch P Wien Med Wochenschr; 1992; 142(18):418-22. PubMed ID: 1475988 [TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927 [TBL] [Abstract][Full Text] [Related]
14. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group. Festen HP; Schenk E; Tan G; Snel P; Nelis F Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Seripa D; Perri F; Niro V; Paris F; Andriulli A; Di Mario F J Am Geriatr Soc; 2006 Oct; 54(10):1537-42. PubMed ID: 17038071 [TBL] [Abstract][Full Text] [Related]
16. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children. Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529 [TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis. Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251 [TBL] [Abstract][Full Text] [Related]